Professor Jacob George is Professor of Cardiovascular Medicine & Therapeutics at the University of Dundee Medical School. Professionally, he is a Consultant Physician in qualified in Clinical Pharmacology and General Internal Medicine and is an accredited European Hypertension Specialist. His clinical interest is in managing patients with high Cardiovascular risk and he is Clinical Lead for the Cardiovascular Risk Service in Tayside. His research interests are focused on managing cardiovascular risk factors such as left ventricular hypertrophy, salt and smoking/vaping. His research publications have been covered by more than 50 news organizations worldwide and he has conducted more than 80 media interviews including live television broadcasts to national and international media on the results of his research. He is actively involved in Medicines Governance in the UK being the National Clinical Lead for the Scottish Medicines Consortium. In this capacity, he sits on the Steering Group of the Innovative Licensing and Access Pathway (ILAP), a joint initiative between the MHRA, NICE,SMC and AWTTC. Locally, he is Chair of the Medicines Advisory Group and is a member of the PACS Tier 2 Committee. He also sits on the National Review Panel for drugs not approved by the SMC. He was recently appointed by the Minister of Health, Malaysia as an International Expert Member of the Malaysian Scientific Review Panel for Phase I Clinical Trials.

Morven is a cardiology nurse with almost 30 years of experience in a plethora of speciality clinical roles involving establishing and running innovative person-centred cardiology services such as a nurse led atrial fibrillation service. She has worked nationally for the British Heart Foundation testing, implementing, and supporting development new pathways of care. She is passionate about education and has worked in healthcare education in both further education & university settings. She led the codesign of the implementation plan of Scottish Cardiac Audit Programme, in collaboration with those with lived experience, clinicians and service providers. She currently works in Forth Valley as the Quality and Safety Lead with a passion of supporting codesign improvement of care with service users.

Dr Alan G Begg has a long interest and involvement in cardiovascular disease initiatives and associated service development. He is a Fellow of the Royal College of Physicians Edinburgh (FRCPE) and a Fellow of the Royal College of General Practitioners (FRCGP). He received the RCGP Scotland Alastair Donald Award in recognition of his teaching and research role in general practice and was until recently a Trustee of Chest Heart and Stroke Scotland (CHSS). He represents general practice on the steering group of the National Inherited Cardiac Conditions Network. He has been active in a large range of guideline developments, their implementation, quality standards development and technology appraisals. He writes widely on the topic of cardiovascular disease and is presently a co-editor of Practical Diabetes.